Report Detail
Global Argatroban Market Research Report 2012-2024
- RnM3567348 |
- 01 July, 2019 |
- Global |
- 85 Pages |
- HeyReport |
- Other
Summary
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
The global Argatroban market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Argatroban Powder
Argatroban Injection
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Pfizer
SANDOZ
GlaxoSmithKline
fresenius-kabi
Eagle Pharmaceuticals
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries
WEST-WARD
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 Argatroban Powder
- 1.2.1.2 Argatroban Injection
- 1.2.2 by Application
- 1.2.2.1 Heparin-induced thrombocytopenia (HIT)
- 1.2.2.2 Percutaneous Coronary Intervention
- 1.2.2.3 Cerebral arterial thrombosis
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 Argatroban Powder Market, 2013-2018
- 4.1.2 Argatroban Injection Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 Argatroban Powder Market Forecast, 2019-2024
- 4.2.2 Argatroban Injection Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 Heparin-induced thrombocytopenia (HIT) Market, 2013-2018
- 5.1.2 Percutaneous Coronary Intervention Market, 2013-2018
- 5.1.3 Cerebral arterial thrombosis Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 Heparin-induced thrombocytopenia (HIT) Market Forecast, 2019-2024
- 5.2.2 Percutaneous Coronary Intervention Market Forecast, 2019-2024
- 5.2.3 Cerebral arterial thrombosis Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Global Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 Pfizer
- 8.2 SANDOZ
- 8.3 GlaxoSmithKline
- 8.4 fresenius-kabi
- 8.5 Eagle Pharmaceuticals
- 8.6 Mitsubishi Tanabe Pharma
- 8.7 Teva Pharmaceutical Industries
- 8.8 WEST-WARD
9 Conclusion
Summary:
Get latest Market Research Reports on Global Argatroban . Industry analysis & Market Report on Global Argatroban is a syndicated market report, published as Global Argatroban Market Research Report 2012-2024. It is complete Research Study and Industry Analysis of Global Argatroban market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
